ClinicalTrials.gov record
Withdrawn Phase 3 Interventional

Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro

ClinicalTrials.gov ID: NCT04254380

Public ClinicalTrials.gov record NCT04254380. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Randomized, Multicenter, Phase 3 Study to Compare the Immunogenicity, Efficacy, and Safety of Gan & Lee Insulin Lispro Injection to Humalog in Adult Subjects With Type 1 Diabetes Mellitus (T1DM)

Study identification

NCT ID
NCT04254380
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gan and Lee Pharmaceuticals, USA
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Not listed

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 3, 2019
Primary completion
Jan 26, 2020
Completion
Jan 26, 2020
Last update posted
Feb 4, 2020

2019 – 2020

United States locations

U.S. sites
56
U.S. states
19
U.S. cities
53
Facility City State ZIP Site status
Advanced Research Center Anaheim California 92805
Valley Research Fresno California 93720
Angel City Research, Inc. Los Angeles California 90057
California Medical Research Association Northridge California 91324
Mills-Peninsula Health Services San Mateo California 94401
Care Access Research - Santa Clarita Santa Clarita California 91321
Metabolic Institute of America Tarzana California 91356
University of Colorado School of Medicine Aurora Colorado 80045
IMMUNOe International Research Centers - Longmont Longmont Colorado 80501
Chase Medical Research of Greater New Haven Hamden Connecticut 06517
The Center for Diabetes and Endocrine Care Fort Lauderdale Florida 33312
M & O Clinical Research Fort Lauderdale Florida 33316
Sweet Hope Research Specialty Inc. Hialeah Florida 33016
Homestead Associates in Research Homestead Florida 33032
Med Research of Florida Miami Florida 33186
Suncoast Clinical Research - Pasco County New Port Richey Florida 34652
Florida Institute for Clinical Research, LLC Orlando Florida 32825
Ormond Beach Clinical Research Ormond Beach Florida 32174
Suncoast Clinical Research - Pinellas County Palm Harbor Florida 34684
Meridien Research - Spring Hill Spring Hill Florida 34609
Metabolic Research Institute West Palm Beach Florida 33401
Atlanta Diabetes Associates Atlanta Georgia 30318
IACT Health - Columbus Regional Medical Group Endocrine Consultants - Columbus Columbus Georgia 31904
IACT Health - Columbus Regional Medical Group Endocrine Consultants Newnan Georgia 30265
Endocrine Research Solutions Roswell Georgia 30076
Cedar Crosse Research Center Chicago Illinois 60607
Midwest CRC Crystal Lake Illinois 60012
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265
Kentucky Diabetes Endocrinology Center Lexington Kentucky 40503
Bay West Endocrinology Associates Baltimore Maryland 21204
BTC Network - Capital Diabetes and Endocrine Associates - Camp Springs Camp Springs Maryland 20746
Endocrine & Metabolic Consultants Rockville Maryland 20852
Quality Clinical Research Omaha Nebraska 68134
Palm Research Center Las Vegas Nevada 89148
BTC Network - Garden State Endocrinology - Brick Brick New Jersey 08723
The Endocrine Group, LLP Albany New York 12206
North Shore Diabetes and Endocrine Associates New Hyde Park New York 11042
University Physicians Group Staten Island New York 10301
PharmQuest Greensboro North Carolina 27408
Physicians East - Greenville Greenville North Carolina 27834
Carteret Medical Group - Morehead City Morehead City North Carolina 28557
Endocrinology Research Associates Columbus Ohio 43201
Your Diabetes Endocrine Nutrition Group, Inc. Mentor Ohio 44060
Intend Research Norman Oklahoma 73069
Lynn Institute of Stillwater Stillwater Oklahoma 73111
Care Access Research - Warwick Warwick Rhode Island 02886
University Diabetes & Endocrine Consultants Chattanooga Tennessee 37411
Amarillo Medical Specialists Amarillo Texas 79106
Austin Regional Clinic Austin Texas 78704
Texas Diabetes & Endocrinology - Central Austin Austin Texas 78731
Research Institute of Dallas Dallas Texas 75231
University of Texas Southwestern Medical Center Dallas Texas 75390
El Paso Medical Research Institute El Paso Texas 79935
Pioneer Research Solutions Houston Texas 77099
Austin Regional Clinic - Kelly Lane Pflugerville Texas 78660
Clinical Trials of Texas, Inc. San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04254380, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 4, 2020 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04254380 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →